Eagle Ridge Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $760K | Buy |
1,460
+34
| +2% | +$17.7K | 0.07% | 82 |
|
|
2024
Q3 | $882K | Buy |
1,426
+7
| +0.5% | +$4.33K | 0.08% | 75 |
|
|
2024
Q2 | $785K | Buy |
1,419
+170
| +14% | +$94K | 0.07% | 78 |
|
|
2024
Q1 | $726K | Buy |
1,249
+352
| +39% | +$205K | 0.07% | 83 |
|
|
2023
Q4 | $476K | Sell |
897
-309
| -26% | -$164K | 0.05% | 102 |
|
|
2023
Q3 | $610K | Sell |
1,206
-26
| -2% | -$13.2K | 0.07% | 89 |
|
|
2023
Q2 | $643K | Buy |
1,232
+14
| +1% | +$7.31K | 0.07% | 90 |
|
|
2023
Q1 | $702K | Sell |
1,218
-95
| -7% | -$54.8K | 0.08% | 85 |
|
|
2022
Q4 | $723K | Buy |
1,313
+31
| +2% | +$17.1K | 0.08% | 87 |
|
|
2022
Q3 | $650K | Hold |
1,282
| – | – | 0.08% | 87 |
|
|
2022
Q2 | $696K | Buy |
1,282
+264
| +26% | +$143K | 0.08% | 85 |
|
|
2022
Q1 | $601K | Buy |
1,018
+272
| +36% | +$161K | 0.06% | 94 |
|
|
2021
Q4 | $498K | Buy |
+746
| New | +$498K | 0.05% | 109 |
|
|
2020
Q4 | – | Sell |
-700
| Closed | -$309K | – | 143 |
|
|
2020
Q3 | $309K | Hold |
700
| – | – | 0.04% | 113 |
|
|
2020
Q2 | $254K | Buy |
+700
| New | +$254K | 0.04% | 111 |
|
|
2020
Q1 | – | Sell |
-722
| Closed | -$235K | – | 151 |
|
|
2019
Q4 | $235K | Hold |
722
| – | – | 0.03% | 145 |
|
|
2019
Q3 | $210K | Hold |
722
| – | – | 0.03% | 144 |
|
|
2019
Q2 | $212K | Buy |
+722
| New | +$212K | 0.03% | 147 |
|